CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | POON CHRISTINE A Director | Option exercise · Non-Qualified Stock Option (right to buy) | −10,838 | 0 | ||
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −55 | $1,140.31 | $63K | 54,614 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −48 | $1,142.94 | $55K | 54,566 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −79 | $1,143.28 | $90K | 54,487 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −45 | $1,144.89 | $52K | 54,442 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −148 | $1,145.58 | $170K | 54,294 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −51 | $1,146.60 | $58K | 54,243 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −537 | $1,148.52 | $617K | 53,706 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −294 | $1,149.60 | $338K | 53,412 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −844 | $1,150.41 | $971K | 52,568 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −185 | $1,151.46 | $213K | 52,383 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −197 | $1,152.36 | $227K | 52,186 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −987 | $1,153.74 | $1.1M | 51,199 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −777 | $1,154.66 | $897K | 50,422 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −402 | $1,155.76 | $465K | 50,020 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −1,016 | $1,156.43 | $1.2M | 49,004 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −178 | $1,157.41 | $206K | 48,826 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −189 | $1,158.78 | $219K | 48,637 |
| 2024-08-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −331 | $1,159.69 | $384K | 48,306 |
| 2024-08-13 | MURPHY ANDREW J EVP Research | Option exercise 10b5-1 | +20,000 | $399.66 | $8.0M | 68,306 |
Page 20 of 105 · 2,088 trades